<DOC>
	<DOC>NCT00565890</DOC>
	<brief_summary>In order to determine the efficacy and safety of thyroxine replacement, a randomized clinical trial of thyroxine supplementation for VLBW infant with hypothyroxinemia during the first month of age is conducted.</brief_summary>
	<brief_title>Supplemental Thyroxine Treatment for Preterm Infants With Hypothyroxinemia</brief_title>
	<detailed_description>A prospective randomized unmasked controlled trial is conducted. Newborn infants with birth weight less than 1500g are randomized into thyroxine treatment or un-treatment group.</detailed_description>
	<criteria>Birth weight: less than 1500g Gestation: 22 weeks 0 day ≤ Serum free thyroxine level lower than 0.8 ng/dl Serum thyrotropin lower than 10 μU/ml Age of between 2 and 4 weeks after birth Informed consent any known thyroid disease in mother</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>4 Weeks</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>very low birth weight infant</keyword>
	<keyword>hypothyroxinemia</keyword>
	<keyword>outcomes</keyword>
</DOC>